Amphiphysin II siRNA (h) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) New Synthetic Lethality Re-Sensitizing Platinum-Refractory Cancer Cells to Cisplatin In Vitro: The Rationale to Co-Use PARP and ATM InhibitorsInternational journal of molecular sciencesDecember 11, 2021Folk WP, Kumari A, Iwasaki T, Cassimere EK, Pyndiah S, Martin E, Homlar K, Sakamuro D.

(2) Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatinThe Journal of biological chemistryApril 5, 2019Folk WP, Kumari A, Iwasaki T, Pyndiah S, Johnson JC, Cassimere EK, Abdulovic-Cui AL, Sakamuro D.

(3) Phosphorylation of Serine 225 in Hepatitis C Virus NS5A Regulates Protein-Protein InteractionsJournal of virologySeptember 1, 2017Goonawardane N, Gebhardt A, Bartlett C, Pichlmair A, Harris M.

(5) The c-MYC-interacting proapoptotic tumor suppressor BIN1 is a transcriptional target for E2F1 in response to DNA damageCell death and differentiationDecember 1, 2009Cassimere EK, Pyndiah S, Sakamuro D.VA, USA), an RB siRNA expression vector (pKD-RB-v3; Millipore, Billerica, MA, USA), and a BIN1 siRNA (sc-29804; Santa Cruz Biotechnology, CA, USA), respectively. Scramble (control) siRNA (sc-37007) was used as the

Amphiphysin II siRNA (h)